Twelve Major US Health Systems Join Forces to Validate AI Diagnostics at Scale

Israeli medical AI company Aidoc has assembled a coalition of 12 major U.S. health systems to collaboratively develop, test, and validate AI-assisted diagnostic workflows in what represents a significant shift from isolated pilot projects to coordinated, multi-institutional deployment. The Diagnostic AI Consortium, announced recently, brings together institutions treating nearly 20 million patients annually with the goal of accelerating diagnosis times while addressing critical physician workforce shortages, particularly in radiology.

From Pilots to Infrastructure: A New Validation Model

The consortium includes prominent health systems such as Advocate Health, Cedars-Sinai Health System, Hartford HealthCare, Houston Methodist, Mercy, Mount Sinai Health System, Northwell Health, Northwestern Medicine, Sutter Health, University of Florida Health, University Hospitals of Cleveland, and WellSpan Health. Rather than each institution independently evaluating AI tools, the collaborative approach aims to establish shared governance frameworks and generate coordinated evidence on safety, quality, and diagnostic speed.

Aidoc will provide its CARE clinical AI foundation model and aiOS enterprise AI operating system as the technical infrastructure for the consortium. The company's technology is currently deployed in nearly 2,000 hospitals and supports analysis of approximately 60 million patient cases annually, having analyzed more than 150 million cases overall.

First results from the consortium are expected to be published in 2027, potentially establishing industry benchmarks for diagnostic AI performance across diverse patient populations and clinical settings.

Addressing a Growing Workforce Crisis

The initiative responds to mounting pressure on radiology departments nationwide. According to data from the Harvey L. Neiman Health Policy Institute cited in the announcement, outpatient imaging interpretation turnaround times more than doubled between 2014 and 2023. Radiologists have been leaving the profession at higher rates since 2020, with workforce shortages projected to persist for decades.

These capacity constraints create delays in diagnosis and treatment, particularly for time-sensitive conditions where imaging interpretation speed can significantly impact patient outcomes. The consortium's focus on measuring diagnostic speed alongside safety and quality metrics reflects the dual challenge of maintaining clinical rigor while addressing operational pressures.

Balancing Innovation with Validation

Elad Walach, Aidoc's CEO and co-founder, emphasized the consortium's measured approach, noting the importance of proceeding "iteratively and together" to balance speed with safety. This collaborative validation model may address persistent concerns about AI deployment in healthcare, including regulatory requirements, clinical validation standards, and equity considerations across diverse patient populations and equipment configurations.

For Aidoc, the consortium strategy positions the company as an infrastructure provider and industry convener rather than simply a point-solution vendor. The multi-institutional data sharing and standardized workflows enabled by the consortium could create network effects that differentiate the company as diagnostic AI moves from experimental adoption to scaled enterprise deployment.

Whether this model successfully accelerates evidence generation while distributing implementation risk remains to be demonstrated, but the consortium represents a notable evolution in how healthcare AI companies approach clinical validation and market adoption.

Sources

1. Aidoc, 12 US health systems launch consortium to speed diagnosis with AI — Ynetnews.com